EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The survival benefit associated with complete macroscopic resection in epithelial ovarian cancer is histotype specific

Joanna M Porter, Iona McFarlane, Clare Bartos, Michael Churchman, James May, C Simon Herrington, Kathryn C Connolly, Neil A J Ryan, Robert L Hollis iD

JNCI Cancer Spectrum · 2024

DOI: 10.1093/jncics/pkae049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI Cancer Spectrum, 2024. Verfasst von Joanna M Porter und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, …. Hauptthemen laut MEDLINE: Ovarian Neoplasms, SEER Program, Carcinoma, Ovarian Epithelial. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Complete macroscopic resection is a key factor associated with prolonged survival in ovarian cancer. However, most evidence derives from high-grade serous ovarian carcinoma, and the benefit of complete macroscopic resection in other histotypes is poorly characterized. We sought to determine which histotypes derive the greatest benefit from complete macroscopic resection to better inform future decisions on radical cytoreductive efforts.

Methods

We performed multivariable analysis of disease-specific survival across 2 independent patient cohorts to determine the magnitude of benefit associated with complete macroscopic resection within each histotype.

Results

Across both cohorts (Scottish: n = 1622; Surveillance, Epidemiology, and End Results [SEER]: n = 18 947), complete macroscopic resection was associated with prolonged disease-specific survival; this was more marked in the Scottish cohort (multivariable hazard ratio [HR] = 0.44, 95% confidence interval [CI] = 0.37 to 0.52 vs HR = 0.59, 95% CI = 0.57 to 0.62 in SEER). In both cohorts, clear cell ovarian carcinoma was among the histotypes to benefit most from complete macroscopic resection (multivariable HR = 0.23 and HR = 0.50 in Scottish and SEER cohorts, respectively); high-grade serous ovarian carcinoma patients demonstrated highly statistically significant and clinically meaningful survival benefit, but this was of lower magnitude than in clear cell ovarian carcinoma and endometrioid ovarian carcinoma across both cohorts. The benefit derived in low-grade serous ovarian carcinoma is also high (multivariable HR = 0.27 in Scottish cohort). Complete macroscopic resection was associated with prolonged survival in mucinous ovarian carcinoma patients in the SEER cohort (multivariable HR = 0.65), but the association failed to reach statistical significance in the Scottish cohort.

Conclusions

The overall ovarian cancer patient population demonstrates clinically significant survival benefit associated with complete macroscopic resection; however, the magnitude of benefit differs between histotypes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsSEER ProgramCarcinoma, Ovarian EpithelialHumansFemaleMiddle AgedAgedScotlandAdenocarcinoma, Clear CellCarcinoma, EndometrioidCytoreduction Surgical ProceduresCystadenocarcinoma, SerousAdenocarcinoma, MucinousAdultNeoplasms, Glandular and EpithelialProportional Hazards ModelsMultivariate AnalysisUnited States

Autor:innen und Institutionen

  • The Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • The Royal Infirmary of Edinburgh, NHS Lothian, Edinburgh, UK.
  • Edinburgh Cancer Centre, Western General Hospital, NHS Lothian, Edinburgh, UK.

ORCID-Profile: Robert L Hollis

Förderung

  • Cancer Research UK

Zitieren

APA

Porter, J. M., McFarlane, I., Bartos, C., Churchman, M., May, J., Herrington, C. S., Connolly, K. C., Ryan, N. A. J., & Hollis, R. L. (2024). The survival benefit associated with complete macroscopic resection in epithelial ovarian cancer is histotype specific. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkae049

Vancouver

Porter JM, McFarlane I, Bartos C, Churchman M, May J, Herrington CS, et al. The survival benefit associated with complete macroscopic resection in epithelial ovarian cancer is histotype specific. JNCI Cancer Spectrum. 2024. doi:10.1093/jncics/pkae049

BibTeX
@article{Porter2024,
  author = {Porter, Joanna M and McFarlane, Iona and Bartos, Clare and Churchman, Michael and May, James and Herrington, C Simon and Connolly, Kathryn C and Ryan, Neil A J and Hollis, Robert L},
  title = {The survival benefit associated with complete macroscopic resection in epithelial ovarian cancer is histotype specific},
  journal = {JNCI Cancer Spectrum},
  year = {2024},
  doi = {10.1093/jncics/pkae049}
}
Kostenlos starten →